The interleukin-13 receptor α2 (IL-13Rα2) and the erythropoietin-producing hepatocellular receptor A2 (EphA2) have been identified as playing crucial roles in tumor growth and progression [2,3]. This evidence concerns the gene EPHA2 and neoplasm.